<DOC>
	<DOCNO>NCT00162292</DOCNO>
	<brief_summary>The purpose clinical research study learn safe rheumatoid arthritis patient take BMS-582949 along methotrexate .</brief_summary>
	<brief_title>Multiple Ascending Dose Study BMS-582949 Patients With Stable Rheumatoid Arthritis Methotrexate Background</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Age 1870 year Diagnosis RA â‰¥6 month Swollen tender joint ESR &gt; ULN . Subject must stable dos MTX Women Childbearing Potential Serum transaminase level &gt; ULN CK &gt; ULN Can take Orencia Remicade within 8 week baseline , Humira Enbrel within 4 week baseline Use H2 blocker Proton Pump inhibitor study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>